Date: 2016-05-04
Type of information: IPO
Company: Poxel (France)
Investors:
Amount:
Funding type: IPO
Planned used:
Others: * On May 4, 2016, Poxel announced that it plans to conduct a registered initial public offering in the United States. The timing, number of securities and price of the proposed offering have not yet been determined.
Therapeutic area: Metabolic diseases
